Evolution of Precision Oncology, Personalized Medicine, and Molecular Tumor Boards

Yu Fujiwara, Shumei Kato, Razelle Kurzrock

Open source

DOI
10.1016/j.hoc.2026.05.019
Published
2026-10
Container
Hematology/Oncology Clinics of North America
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.hoc.2026.05.019,
  title = {Evolution of Precision Oncology, Personalized Medicine, and Molecular Tumor Boards},
  author = {Yu Fujiwara and Shumei Kato and Razelle Kurzrock},
  year = {2026},
  journal = {Hematology/Oncology Clinics of North America},
  doi = {10.1016/j.hoc.2026.05.019},
  url = {https://doi.org/10.1016/j.hoc.2026.05.019}
}

RIS

TY  - JOUR
TI  - Evolution of Precision Oncology, Personalized Medicine, and Molecular Tumor Boards
AU  - Yu Fujiwara
AU  - Shumei Kato
AU  - Razelle Kurzrock
PY  - 2026
JO  - Hematology/Oncology Clinics of North America
DO  - 10.1016/j.hoc.2026.05.019
UR  - https://doi.org/10.1016/j.hoc.2026.05.019
ER  - 

APA

Fujiwara, Y., Kato, S., & Kurzrock, R. (2026). Evolution of Precision Oncology, Personalized Medicine, and Molecular Tumor Boards. Hematology/Oncology Clinics of North America. https://doi.org/10.1016/j.hoc.2026.05.019

Source records